Flumatinib Mesylate, CAS 895519-91-2 Sole GMP Manufacturer
Flumatinib Mesylate, CAS 895519-91-2 stable novel crystalline or amorphous form both we have, Flumatinib Mesylate, CAS 895519-91-2no any IP problem. Flumatinib Mesylate, CAS 895519-91-2 DMF filling, free sample of Flumatinib Mesylate, CAS 895519-91-2.
EOS Med Chem have already carried out Flumatinib Mesylate, CAS 895519-91-2 batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For Flumatinib Mesylate, CAS 895519-91-2 , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.
Below is Flumatinib Mesylate, CAS 895519-91-2 Intermeidates list, most from GMP plant:
"FlumatinibMesylate, CAS 895519-91-2;
895519-90-1(free) Intermediate, 637354-25-7, stock 1.3kg, assay 98.1%, White powder."
"FlumatinibMesylate, CAS 895519-91-2;
895519-90-1(free) Intermediate, 51984-61-3, stock 5.1kg, assay 98.9%, White powder."
"FlumatinibMesylate, CAS 895519-91-2;
895519-90-1(free) Intermediate, 895519-80-9, stock 4.8kg, assay 98.8%, White powder."
"FlumatinibMesylate, CAS 895519-91-2;
895519-90-1(free) Intermediate, 895519-81-0, stock 2.3kg, assay 98%, White powder."
"FlumatinibMesylate, CAS 895519-91-2;
895519-90-1(free) Intermediate, 859282-11-4, stock 8.5kg, assay 98.6%, White powder."
"FlumatinibMesylate, CAS 895519-91-2;
895519-90-1(free) Intermediate, 895519-90-1, stock 9.9kg, assay 98.4%, White powder."
Flumatinib Mesylate, CAS 895519-91-2 HNMR, MASS, COA, MSDS we have.
Flumatinib Mesylate, CAS 895519-91-2, free sample, welcome to ask:
2019 CHINA CPHI E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
Flumatinib Mesylate, CAS 895519-91-2 stable novel crystalline or amorphous form both we have, Flumatinib Mesylate, CAS 895519-91-2no any IP problem. Flumatinib Mesylate, CAS 895519-91-2 DMF filling, free sample of Flumatinib Mesylate, CAS 895519-91-2.
EOS Med Chem have already carried out Flumatinib Mesylate, CAS 895519-91-2 batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For Flumatinib Mesylate, CAS 895519-91-2 , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.
Below is Flumatinib Mesylate, CAS 895519-91-2 Intermeidates list, most from GMP plant:
"FlumatinibMesylate, CAS 895519-91-2;
895519-90-1(free) Intermediate, 637354-25-7, stock 1.3kg, assay 98.1%, White powder."
"FlumatinibMesylate, CAS 895519-91-2;
895519-90-1(free) Intermediate, 51984-61-3, stock 5.1kg, assay 98.9%, White powder."
"FlumatinibMesylate, CAS 895519-91-2;
895519-90-1(free) Intermediate, 895519-80-9, stock 4.8kg, assay 98.8%, White powder."
"FlumatinibMesylate, CAS 895519-91-2;
895519-90-1(free) Intermediate, 895519-81-0, stock 2.3kg, assay 98%, White powder."
"FlumatinibMesylate, CAS 895519-91-2;
895519-90-1(free) Intermediate, 859282-11-4, stock 8.5kg, assay 98.6%, White powder."
"FlumatinibMesylate, CAS 895519-91-2;
895519-90-1(free) Intermediate, 895519-90-1, stock 9.9kg, assay 98.4%, White powder."
Flumatinib Mesylate, CAS 895519-91-2 HNMR, MASS, COA, MSDS we have.
Flumatinib Mesylate, CAS 895519-91-2, free sample, welcome to ask:
2019 CHINA CPHI E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
